Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 211

1.

Conservative surgery vs. duodeneopancreatectomy in primary duodenal gastrointestinal stromal tumors (GIST): A retrospective review of 114 patients from the French Sarcoma Group (FSG).

Duffaud F, Meeus P, Bachet JB, Cassier P, Huynh TK, Boucher E, Bouché O, Moutardier V, le Cesne A, Landi B, Marchal F, Bay JO, Bertucci F, Spano JP, Stoeckle E, Collard O, Chaigneau L, Isambert N, Lebrun-Ly V, Mancini J, Blay JY, Bonvalot S.

Eur J Surg Oncol. 2014 May 28. pii: S0748-7983(14)00430-2. doi: 10.1016/j.ejso.2014.04.011. [Epub ahead of print]

PMID:
24994075
[PubMed - as supplied by publisher]
2.

Long-term recurrence of soft tissue sarcomas: Prognostic factors and implications for prolonged follow-up.

Toulmonde M, Le Cesne A, Mendiboure J, Blay JY, Piperno-Neumann S, Chevreau C, Delcambre C, Penel N, Terrier P, Ranchère-Vince D, Lae M, Le Guellec S, Michels JJ, Robin YM, Bellera C, Italiano A.

Cancer. 2014 Jun 18. doi: 10.1002/cncr.28836. [Epub ahead of print]

PMID:
24942887
[PubMed - as supplied by publisher]
3.

Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group.

Toulmonde M, Bonvalot S, Méeus P, Stoeckle E, Riou O, Isambert N, Bompas E, Jafari M, Delcambre-Lair C, Saada E, Le Cesne A, Le Péchoux C, Blay JY, Piperno-Neumann S, Chevreau C, Bay JO, Brouste V, Terrier P, Ranchère-Vince D, Neuville A, Italiano A; French Sarcoma Group.

Ann Oncol. 2014 Mar;25(3):735-42. doi: 10.1093/annonc/mdt577.

PMID:
24567518
[PubMed - in process]
4.

Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk.

Fiore M, Coppola S, Cannell AJ, Colombo C, Bertagnolli MM, George S, Le Cesne A, Gladdy RA, Casali PG, Swallow CJ, Gronchi A, Bonvalot S, Raut CP.

Ann Surg. 2014 May;259(5):973-8. doi: 10.1097/SLA.0000000000000224.

PMID:
24477160
[PubMed - indexed for MEDLINE]
5.

Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group.

Gronchi A, Colombo C, Le Péchoux C, Dei Tos AP, Le Cesne A, Marrari A, Penel N, Grignani G, Blay JY, Casali PG, Stoeckle E, Gherlinzoni F, Meeus P, Mussi C, Gouin F, Duffaud F, Fiore M, Bonvalot S; ISG and FSG.

Ann Oncol. 2014 Mar;25(3):578-83. doi: 10.1093/annonc/mdt485. Epub 2013 Dec 9.

PMID:
24325833
[PubMed - in process]
6.

Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial.

Penel N, Ray-Coquard I, Bal-Mahieu C, Chevreau C, Le Cesne A, Italiano A, Bompas E, Clisant S, Baldeyrou B, Lansiaux A, Robin YM, Bay JO, Piperno-Neumann S, Blay JY, Fournier C.

Target Oncol. 2013 Nov 12. [Epub ahead of print]

PMID:
24218035
[PubMed - as supplied by publisher]
7.

GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study.

Italiano A, Le Cesne A, Bellera C, Piperno-Neumann S, Duffaud F, Penel N, Cassier P, Domont J, Takebe N, Kind M, Coindre JM, Blay JY, Bui B.

Ann Oncol. 2013 Nov;24(11):2922-6. doi: 10.1093/annonc/mdt391.

PMID:
24170610
[PubMed - indexed for MEDLINE]
8.

Optimizing tyrosine kinase inhibitor therapy in gastrointestinal stromal tumors: exploring the benefits of continuous kinase suppression.

Le Cesne A, Blay JY, Reichardt P, Joensuu H.

Oncologist. 2013;18(11):1192-9. doi: 10.1634/theoncologist.2012-0361. Epub 2013 Oct 17.

PMID:
24136010
[PubMed - in process]
9.

Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group.

Isambert N, Ray-Coquard I, Italiano A, Rios M, Kerbrat P, Gauthier M, Blouet A, Chaigneau L, Duffaud F, Piperno-Neumann S, Kurtz JE, Girard N, Collard O, Bompas E, Penel N, Bay JO, Guillemet C, Collin F, Blay JY, Le Cesne A, Thariat J.

Eur J Cancer. 2014 Jan;50(1):128-36. doi: 10.1016/j.ejca.2013.09.012. Epub 2013 Oct 14.

PMID:
24135684
[PubMed - indexed for MEDLINE]
10.

Advanced chondrosarcomas: role of chemotherapy and survival.

Italiano A, Mir O, Cioffi A, Palmerini E, Piperno-Neumann S, Perrin C, Chaigneau L, Penel N, Duffaud F, Kurtz JE, Collard O, Bertucci F, Bompas E, Le Cesne A, Maki RG, Ray Coquard I, Blay JY.

Ann Oncol. 2013 Nov;24(11):2916-22. doi: 10.1093/annonc/mdt374. Epub 2013 Oct 7.

PMID:
24099780
[PubMed - indexed for MEDLINE]
11.

Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought.

Bonvalot S, Ternès N, Fiore M, Bitsakou G, Colombo C, Honoré C, Marrari A, Le Cesne A, Perrone F, Dunant A, Gronchi A.

Ann Surg Oncol. 2013 Dec;20(13):4096-102. doi: 10.1245/s10434-013-3197-x. Epub 2013 Sep 20.

PMID:
24052312
[PubMed - indexed for MEDLINE]
12.

Epithelioid sarcoma: need for a multimodal approach to maximize the chances of curative conservative treatment.

Levy A, Le Péchoux C, Terrier P, Bouaita R, Domont J, Mir O, Coppola S, Honoré C, Le Cesne A, Bonvalot S.

Ann Surg Oncol. 2014 Jan;21(1):269-76. doi: 10.1245/s10434-013-3247-4. Epub 2013 Sep 18.

PMID:
24046109
[PubMed - in process]
13.

Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials.

Cesne AL, Judson I, Maki R, Grosso F, Schuetze S, Mehren MV, Chawla SP, Demetri GD, Nieto A, Tanovic A, Blay JY.

Br J Cancer. 2013 Oct 1;109(7):1717-24. doi: 10.1038/bjc.2013.524. Epub 2013 Sep 10.

PMID:
24022187
[PubMed - indexed for MEDLINE]
14.

Efficacy and safety of trabectedin as an early treatment for advanced or metastatic liposarcoma and leiomyosarcoma.

Blay JY, Casali P, Nieto A, Tanović A, Le Cesne A.

Future Oncol. 2014 Jan;10(1):59-68. doi: 10.2217/fon.13.163. Epub 2013 Aug 29.

PMID:
23987833
[PubMed - in process]
15.

CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.

Colombo C, Miceli R, Lazar AJ, Perrone F, Pollock RE, Le Cesne A, Hartgrink HH, Cleton-Jansen AM, Domont J, Bovée JV, Bonvalot S, Lev D, Gronchi A.

Cancer. 2013 Oct 15;119(20):3696-702. doi: 10.1002/cncr.28271. Epub 2013 Jul 31.

PMID:
23913621
[PubMed - indexed for MEDLINE]
16.

Reply to Letter: A Role for Adjuvant RFA in Managing Hepatic Metastases From Gastrointestinal Stromal Tumors (GIST) After Treatment With Targeted Systemic Therapy Using Kinase Inhibitors.

Hakimé A, Le Cesne A, Deschamps F, Farouil G, Domont J, De Baere T.

Cardiovasc Intervent Radiol. 2013 Aug 3. [Epub ahead of print] No abstract available.

PMID:
23912492
[PubMed - as supplied by publisher]
17.

Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.

Rutkowski P, Gronchi A, Hohenberger P, Bonvalot S, Schöffski P, Bauer S, Fumagalli E, Nyckowski P, Nguyen BP, Kerst JM, Fiore M, Bylina E, Hoiczyk M, Cats A, Casali PG, Le Cesne A, Treckmann J, Stoeckle E, de Wilt JH, Sleijfer S, Tielen R, van der Graaf W, Verhoef C, van Coevorden F.

Ann Surg Oncol. 2013 Sep;20(9):2937-43. doi: 10.1245/s10434-013-3013-7. Epub 2013 Jun 13.

PMID:
23760587
[PubMed - indexed for MEDLINE]
18.

Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy.

Demetri GD, Chawla SP, Ray-Coquard I, Le Cesne A, Staddon AP, Milhem MM, Penel N, Riedel RF, Bui-Nguyen B, Cranmer LD, Reichardt P, Bompas E, Alcindor T, Rushing D, Song Y, Lee RM, Ebbinghaus S, Eid JE, Loewy JW, Haluska FG, Dodion PF, Blay JY.

J Clin Oncol. 2013 Jul 1;31(19):2485-92. doi: 10.1200/JCO.2012.45.5766. Epub 2013 May 28.

PMID:
23715582
[PubMed - indexed for MEDLINE]
19.

13 years of trabectedin, 5 years of Yondelis®: what have we learnt?

Le Cesne A.

Expert Rev Anticancer Ther. 2013 Jun;13(6 Suppl 1):11-9. doi: 10.1586/era.13.49.

PMID:
23638726
[PubMed - indexed for MEDLINE]
20.

Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13.

Bachet JB, Landi B, Laurent-Puig P, Italiano A, Le Cesne A, Lévy P, Safar V, Duffaud F, Blay JY, Emile JF.

Eur J Cancer. 2013 Jul;49(11):2531-41. doi: 10.1016/j.ejca.2013.04.005. Epub 2013 May 3.

PMID:
23648119
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk